股票发售
Search documents
智谱香港公开发售获1159.46倍认购
Zheng Quan Shi Bao Wang· 2026-01-08 00:21
Group 1 - The company announced the results of its H-share issuance, with a total global offering of 37.42 million shares [1] - The offering price was set at HKD 116.20 per share, resulting in net proceeds of approximately HKD 4.173 billion from the global offering [1] - The shares are expected to begin trading on the Hong Kong Stock Exchange on January 8, 2026, at 9:00 AM [1] Group 2 - The Hong Kong public offering was oversubscribed by 1,159.46 times, while the international offering was oversubscribed by 15.28 times [1]
金浔资源于12月31日至1月6日招股,获基石投资认购约6026万美元
Zhi Tong Cai Jing· 2025-12-30 23:02
Group 1 - The company, Jin Xun Resources, plans to globally offer 36.7656 million H-shares at a price of HKD 30 per share, with 10% allocated for Hong Kong and 90% for international sales, and an overallotment option of 15% [1] - The expected trading start date for the H-shares on the Hong Kong Stock Exchange is January 9, 2026 [1] - Jin Xun Resources is a leading manufacturer of high-quality cathode copper, ranking fifth among Chinese producers based on production in the Democratic Republic of the Congo (DRC) and Zambia, with production figures of approximately 16,000 tons and 5,000 tons respectively for 2024 [1] Group 2 - The company's revenue for the years 2022, 2023, 2024, and the six months ending June 30, 2025, were RMB 637 million, RMB 676 million, RMB 1.77 billion, and RMB 596 million, RMB 964 million respectively [2] - Net profits for the same periods were RMB 83.5 million, RMB 29.1 million, RMB 202 million, RMB 93.1 million, and RMB 135 million respectively [2] - The company has entered cornerstone investment agreements with several investors, including Glencore AG and others, agreeing to subscribe for shares totaling approximately USD 60.26 million under certain conditions [2] Group 3 - The estimated net proceeds from the global offering, assuming the share price is HKD 30 and the overallotment option is not exercised, is approximately HKD 1.0426 billion [2] - About 80% of the proceeds will be used to expand the core business, 10% for repaying certain interest-bearing bank loans, and 10% for working capital and general corporate purposes [2]
MINIMAX-WP(00100.HK)12月31日起招股 发售价将为每股151-165港元
Ge Long Hui· 2025-12-30 22:48
Group 1 - The company MINIMAX-WP (00100.HK) plans to globally offer 25,389,220 shares, with 1,269,480 shares available for sale in Hong Kong and 24,119,740 shares for international sale [1] - The subscription period is set from December 31, 2025, to January 6, 2026, with the expected pricing date on January 7, 2026 [1] - The offering price is projected to be between HKD 151.00 and HKD 165.00 per share, with Class A ordinary shares traded in lots of 20 shares [1] Group 2 - China International Capital Corporation and UBS Group are appointed as joint sponsors for the offering [1] - The Class A ordinary shares are expected to commence trading on the Hong Kong Stock Exchange on January 9, 2026 [1]
林清轩香港公开发售获1235.81倍认购 每股发售价77.77港元
Zhi Tong Cai Jing· 2025-12-29 15:00
Core Viewpoint - Lin Qingxuan (02657) has announced the results of its global offering, raising a total of HKD 997 million through the issuance of approximately 13.9665 million H-shares at a price of HKD 77.77 per share [1] Group 1: Offering Details - The global offering consists of approximately 13.9665 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - The subscription for the Hong Kong public offering was oversubscribed by 1,235.81 times, while the international offering was oversubscribed by 19.79 times [1] - Each board lot consists of 50 H-shares, and trading is expected to commence on December 30, 2025, at 9:00 AM on the Hong Kong Stock Exchange [1]
翰思艾泰-B:香港公开发售获3074.09倍认购 每股发售价32港元
Zhi Tong Cai Jing· 2025-12-22 14:36
Core Viewpoint - The company Huan Si Ai Tai-B (03378) has successfully completed its global offering, raising a total of HKD 531 million through the issuance of 18.321 million H shares at a price of HKD 32 per share [1] Summary by Category Offering Details - The global offering consisted of 18.321 million H shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - The expected trading commencement date for the shares on the Hong Kong Stock Exchange is December 23, 2025 [1] Subscription Results - The Hong Kong public offering was oversubscribed by 3,074.09 times, indicating strong demand from local investors [1] - The international offering was oversubscribed by 5.78 times, reflecting significant interest from international investors [1]
诺比侃:香港公开发售获188.74倍认购 每股发售价80港元
Zhi Tong Cai Jing· 2025-12-22 13:48
Core Viewpoint - Nobikang (02635) has announced the results of its share allocation, with a total of 3.7866 million H-shares being globally offered, indicating strong demand in both local and international markets [1] Group 1: Share Allocation Details - The global offering consists of 3.7866 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - The offer price per share is set at HKD 80, resulting in a net fundraising of approximately HKD 257 million from the global offering [1] - Each lot consists of 50 H-shares, and trading is expected to commence on December 23, 2025, at 9:00 AM Hong Kong time on the Hong Kong Stock Exchange [1] Group 2: Subscription Demand - The Hong Kong public offering was oversubscribed by 188.74 times, indicating a high level of interest from local investors [1] - The international offering received a subscription rate of 2.08 times, reflecting solid demand from international investors [1]
诺比侃(02635):香港公开发售获188.74倍认购 每股发售价80港元
智通财经网· 2025-12-22 13:42
Core Viewpoint - Nobikang (02635) has successfully completed its global offering, raising approximately HKD 257 million through the issuance of 3.7866 million H-shares at a price of HKD 80 per share [1] Group 1: Offering Details - The global offering consisted of 3.7866 million H-shares, with 10% allocated for public offering in Hong Kong and 90% for international offering [1] - The shares are expected to commence trading on the Hong Kong Stock Exchange on December 23, 2025, at 9:00 AM Hong Kong time [1] Group 2: Subscription Results - The Hong Kong public offering was oversubscribed by 188.74 times, indicating strong demand from local investors [1] - The international offering saw a subscription rate of 2.08 times, reflecting interest from international investors [1]
壁仞科技(06082.HK)12月22日起招股 发售价将为每股17.0-19.6港元
Ge Long Hui· 2025-12-21 22:41
Core Viewpoint - The company, Wallen Technology (06082.HK), plans to globally offer approximately 248 million H-shares, with a pricing range of HKD 17.00 to HKD 19.60 per share [1] Group 1: Offering Details - The company will offer around 12.3848 million shares in Hong Kong and approximately 235 million shares internationally, subject to reallocation and adjustments based on demand and the exercise of over-allotment options [1] - The subscription period for the shares is set from December 22 to December 29, 2025, with the expected pricing date on December 30, 2025 [1] - The shares are expected to commence trading on the Hong Kong Stock Exchange on January 2, 2026, with a trading unit of 200 shares per lot [1] Group 2: Underwriters - The joint sponsors for the offering include China International Capital Corporation, Ping An Securities (Hong Kong), and Bank of China International [1]
智汇矿业(2546)香港公开发售超额认购5248倍 基石投资者认购占比40.78% 拟于12月19日上市
Xin Lang Cai Jing· 2025-12-18 14:36
Group 1 - The core viewpoint of the news is that Tibet Zhihui Mining Co., Ltd. has successfully completed its global offering, with a fixed issue price of HKD 4.51 per share, raising approximately HKD 550 million in total funds, and a net amount of about HKD 500 million after deducting estimated listing expenses [1][2] - The total number of shares offered in the global sale is 121,952,000 H-shares, with 12,196,000 shares allocated for public offering in Hong Kong and 109,756,000 shares for international placement, without any over-allotment option [1] - The subscription results indicate a high demand, with the Hong Kong public offering receiving 177,542 valid applications, resulting in a subscription rate of 5,248.15 times, while the international placement had a subscription rate of 2.68 times involving 164 participants [1] Group 2 - Several cornerstone investors participated in the offering, including Spico International Limited, which was allocated 32,000,000 shares, and GIGA Industries Limited and Poly Platinum Enterprises Limited, which received 11,086,000 shares and 6,651,000 shares respectively, totaling 49,737,000 shares or 40.78% of the global offering [2] - The joint sponsors for this global offering are Guotai Junan Securities (Hong Kong) Limited and Mai Shi Capital Limited, with trading expected to commence on the Hong Kong Stock Exchange on December 19, 2025, under the stock code 2546 [2]
港股公告掘金 | 果下科技拟全球发售3385.29万股H股 引入惠开香港等基石投资者
Zhi Tong Cai Jing· 2025-12-08 15:25
Major Events - GuoXia Technology (02655) plans to conduct an IPO from December 8 to December 11, offering 33.85 million H-shares and introducing cornerstone investors such as Huikai Hong Kong [1] - Basilea Pharmaceutica AG (02616) has its drug Pujihua® (Pralsetinib Capsules) included in the National Medical Insurance Directory for 2025 [1] - Four Seasons Pharmaceutical (00460) sees its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Shanghai Pharmaceuticals (02607) successfully negotiates and includes Amisulpride Orally Disintegrating Tablets in the National Medical Insurance Directory [1] - Hansoh Pharmaceutical (03692) has its innovative drug Amelotex® approved for two new indications in the updated 2025 National Medical Insurance Directory [1] - Xiansheng Pharmaceutical (02096) sees EnzeShu® and EnDu® included in the updated National Medical Insurance Drug List [1] - Hutchison China MediTech (00013) has its drug Tazverik® included in the first edition of the National Commercial Health Insurance Innovative Drug List [1] - XuanZhu Biotechnology (02575) has its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Yino Pharmaceutical (02591) has its H-shares included in the list of eligible securities for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect [1] - China Metallurgical Group (01618) and its subsidiaries plan to sell non-core business assets for approximately 60.68 billion yuan, focusing on core businesses in metallurgical engineering, non-ferrous metals, and mining engineering [1] - Cambridge Technology (06166) intends to invest a total of 405 million yuan to acquire and subscribe for shares in the Yangzhong Happiness Home Venture Capital Partnership Fund [1] Operating Performance - Dongfeng Motor Group (00489) reports cumulative automobile sales of 1.697 million units in the first 11 months, a year-on-year decrease of approximately 0.3% [2] - New天绿色能源 (00956) achieves a cumulative power generation of 1,336.89 million MWh in the first 11 months, an increase of 8.04% year-on-year [2] - Longyuan Power (00916) reports a cumulative power generation of approximately 6,909.64 million MWh in the first 11 months, a year-on-year growth of 0.41% [2] - Baolong Real Estate (01238) records a total contract sales of approximately 6.666 billion yuan in the first 11 months, a year-on-year decline of 43.2% [2]